Abstract
COVID-19 infection triggers a heightened inflammatory response which in turn, increases thrombosis and thromboembolism. Microvascular thrombosis has been detected in various tissue beds which may account for some of the multi-system organ dysfunction associated with COVID-19. Additional research is needed to understand which prophylactic and therapeutic drug regimens are best for the prevention and treatment of thrombotic complications of COVID-19.
Keywords: COVID-19; Deep vein thrombosis; Myocardial infarction; Pulmonary embolism; SARS-CoV-2; Stroke; Thrombosis.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, stroke, Pulmonary embolism, Myocardial infarction, thrombosis., Deep vein thrombosis, 【초록키워드】 Treatment, thrombosis, Thrombotic complications, Infection, Prophylactic, pulmonary, COVID-19 infection, Pulmonary embolism, Research, Thromboembolism, organ dysfunction, Myocardial infarction, Deep vein thrombosis, Inflammatory response, Trigger, regimen, Deep vein, Microvascular thrombosis, tissue, thrombotic, thrombotic complication, increase, turn, therapeutic drug, with COVID-19, 【제목키워드】 Effect, Extracardiac,
【저자키워드】 COVID-19, SARS-CoV-2, stroke, Pulmonary embolism, Myocardial infarction, thrombosis., Deep vein thrombosis, 【초록키워드】 Treatment, thrombosis, Thrombotic complications, Infection, Prophylactic, pulmonary, COVID-19 infection, Pulmonary embolism, Research, Thromboembolism, organ dysfunction, Myocardial infarction, Deep vein thrombosis, Inflammatory response, Trigger, regimen, Deep vein, Microvascular thrombosis, tissue, thrombotic, thrombotic complication, increase, turn, therapeutic drug, with COVID-19, 【제목키워드】 Effect, Extracardiac,
{{{ 추상적인 }}}
COVID-19 감염은 염증 반응을 증가시켜 혈전증과 혈전색전증을 증가시킵니다. 미세혈관 혈전증은 COVID-19와 관련된 다기관 기관 기능 장애의 일부를 설명할 수 있는 다양한 조직 침대에서 감지되었습니다. COVID-19의 혈전 합병증 예방 및 치료에 어떤 예방 및 치료 약물 요법이 가장 좋은지 이해하려면 추가 연구가 필요합니다.
{{ 키워드: }} 코로나19; 심부정맥 혈전증; 심근 경색증; 폐 색전증; 사스 코로나바이러스 2; 뇌졸중; 혈전증.